Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Magnolia Diagnostics logo — Get Better Sooner

Magnolia Diagnostics

Get Better Sooner

Founded 2016 United States Dallas, United States 13 employees Seed Total: $937.50K Health Care

General Information

Company Name Magnolia Diagnostics
Founded Year 2016
Location United States Dallas, United States
Employees 13
Industries Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Magnolia Diagnostics. To contact Magnolia Diagnostics, visit magnoliadiagnostics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Magnolia Diagnostics compare?

A PDF of Magnolia Diagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Magnolia Diagnostics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Magnolia Diagnostics

Magnolia Diagnostics is a health care startup that aims to revolutionize the way physicians practice medicine and how patients receive care. Their slogan "Get Better Sooner" encapsulates their mission. The company was founded in 2016 and is headquartered in the United States. Magnolia Diagnostics combines custom DNA & RNA infectious disease testing with on-demand couriers, creating a platform to diagnose 85% of all outpatient sick visits within hours. Their approach promises to be faster, cheaper, and better than traditional urgent care visits. The company received a significant boost with a $937.50K Seed Round investment on 05 January 2018, demonstrating investor confidence in their innovative approach. While the specific investors for this round are not disclosed, the financial backing reflects the potential seen in Magnolia Diagnostics' disruptive model. Operating in Austin, Dallas, Fort Worth, and San Antonio, Magnolia Diagnostics has positioned itself in strategic locations within the United States, which could contribute to widespread adoption and scalability. With its promising concept and early investment traction, Magnolia Diagnostics presents an intriguing prospect for venture capitalists seeking opportunities in the evolving health care industry.

Business keywords: Molecular Diagnostics, DNA Testing, RNA Testing, Infectious Disease Testing, Medical Innovation, Physician Practice, Patient Care, Diagnostic Platform, On-demand Couriers, Outpatient Care, Urgent Care Alternative, Fast Diagnosis, Cost-effective Healthcare, Medical Revolution

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $937.50K -
05 Jan 2018

Magnolia Diagnostics Alternatives & Competitors

View All Alternatives
Magnolia Diagnostics vs
EMPE Diagnostics
EMPE Diagnostics Sweden

Confirmatory precision diagnostics for tuberculosis (MDR/XDR-TB) within 3 h even at resource-limited...

Series A
27 employees
Biotechnology, Health Care
Magnolia Diagnostics vs
Iontek Molecular Diagnostics
Iontek Molecular Diagnostics Turkey

Bringing Color to Molecular Diagnostics

1 employees
Digital Health, Health Care
Magnolia Diagnostics vs
Pathnostics - A Diagnostics Solutions Company
Pathnostics - A Diagnostics Solutions Company United States

We pioneer approaches for better patient care and empower physicians to champion patient health toda...

Private Equity
171 employees
Biotechnology, Health Care
View all alternatives

FAQ About Magnolia Diagnostics

Get Better Sooner
Magnolia Diagnostics was founded in 2016.
Magnolia Diagnostics is headquartered in Dallas, United States.
Magnolia Diagnostics operates in Health Care. Its work centres on Molecular Diagnostics, DNA Testing, RNA Testing and Infectious Disease Testing.
Magnolia Diagnostics has approximately 13 employees.
Magnolia Diagnostics has completed 1 funding round, raising a total of $937.50K. The latest funding stage is Seed.
Top alternatives and competitors to Magnolia Diagnostics include EMPE Diagnostics, Iontek Molecular Diagnostics, Pathnostics - A Diagnostics Solutions Company, Fusion Genomics Corporation, Galaxy Diagnostics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Magnolia Diagnostics and EMPE Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Magnolia Diagnostics, https://bouncewatch.com/company/magnolia-diagnostics, updated 30 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes